Abstract
Thyroid nodules are a common clinical dilemma; however, the vast majority are benign. The clinical importance of thyroid nodules rests with the need to detect thyroid cancer, which occurs in 5–10%. The risk depends on factors including age, gender, history of radiation exposure and family history [1, 2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med. 2004;351:1764–71.
Mandel SJ. A 64-year-old woman with a thyroid nodule. JAMA. 2004;292:2632–42.
Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897–904.
Pacini F, Vorontsova T, Demidchik E, et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab. 1997;81:3563–9.
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–1214.
Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006;91:4295–301.
Walsh RM, Watkinson JC, Franklyn J. The management of the solitary thyroid nodule: a review. Clin Otolaryngol. 1999;24:388–97.
Campbell JP, Pillsbury HC. Management of the thyroid nodule. Head Neck. 1989;11:414–25.
Ashcroft MW, Van Herle AJ. Management of thyroid nodules. II Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head Neck Surg. 1981;3:297–322.
The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Guidelines of the Papanicolaou Society of Cytopathology for examination of fine-needle aspiration specimens from thyroid nodules. Diagn Cytopathol. 1996;15:84–9.
Sabel MS, Haque D, Velasco JM, Staren ED. Use of ultrasound-guided fine needle aspiration biopsy in the management of thyroid disease. Am Surg. 1998;64:738–42.
Hatada T, Okada K, Ishii H, Ichii S, Utsunomiya J. Evaluation of ultrasound-guided fine-needle aspiration Biopsy for thyroid nodules. Am J Surg. 1998;175:133–6.
Newkirk KA, Ruigel MD, Jelinek J, et al. Ultrasound-guided fine needle aspiration and thyroid disease. Ootolaryngol Head Neck. 2000;123:700–5.
Alexander EK, Heering JP, Benson CB, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspiration of thyroid nodules. J Clin Endocrinol Metab. 2002;87:4924–7.
Kwak JY, Koo H, Youk JH, et al. Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology. 2010;254:292–300.
Fatourechi V, Hay ID, Mullan BP, et al. Are post-therapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer? Thyroid. 2000;10:573–7.
Sherman SI, Tielens ET, Sostre S, Wharam Jr MD, Ladenson PW. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab. 1994;78:629–34.
Reynolds JC. Percent 131I uptake and post-therapy 131I scans: their role in the management of thyroid cancer. Thyroid. 1997;7:281–4.
Mitchell JC, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery. 2005;138:1166–74. discussion 1174–5.
de Geus-Oei LF, Pieters GF, Bonenkamp JJ, et al. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med. 2006;47:770–5.
Kim JM, Ryu JS, Kim TY, et al. 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab. 2007;92:1630–4.
Sebastianes FM, Cerci JJ, Zanoni PH, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2007;92:4485–8.
Hales NW, Krempl GA, Medina JE. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol. 2008;29:113–8.
King AD, Ahuja AT, To EWH, Tse GMK, Metreweli C. Staging of papillary carcinoma of the thyroid: magnetic resonance imaging vs ultrasound of the neck. Clin Radiol. 2000;55:222–6.
Yousem DM, Scheff AM. Thyroid and parathyroid. In: Som PM, Curtin HD, editors. Head and neck imaging. 3rd ed. St Louis: Mosby; 1996. p. 954–8.
Mazzaferri EL. Managing small thyroid cancers. JAMA. 2006;295:2179–82.
Frates MC, Benson CB, Charboneau JW, et al. Society of Radiologists in Ultrasound. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology. 2005;237:794–800.
Ross DS. Editorial: predicting thyroid malignancy. J Clin Endocrinol Metab. 2006;91:4253–5.
Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30. Erratum in: CA Cancer J Clin 2005;55:259.
Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer. 1985;56:531–8.
Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol. 2007;14:3210–5.
Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002;87:1941–6.
Hagag P, Strauss S, Weiss M. Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid. 1998;8:989–95.
Nam-Goong IS, Kim HY, Gong G, et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf). 2004;60:21–8.
Cronan JJ. Thyroid nodules: is it time to turn off the US machines? Radiology. 2008;247:602–4.
Wong KT, Ahuja AT. Ultrasound of thyroid cancer. Cancer Imaging. 2005;5:157–66.
Frates MC, Benson CB, Doubilet PM, Cibas ES, Marqusee E. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules? J Ultrasound Med. 2003;22:127–31.
Khoo ML, Asa SL, Witterick IJ, Freeman JL. Thyroid calcification and its association with thyroid carcinoma. Head Neck. 2002;24:651–5.
Kim EK, Park CS, Chung WY, Oh KK, Kim DI, Lee JT, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol. 2002;178:687–91.
Peccin S, de Castsro JA, Furlanetto TW, Furtado AP, Brasil BA, Czepielewski MA. Ultrasonography: is it useful in the diagnosis of cancer in thyroid nodules? J Endocrinol Invest. 2002;25:39–43.
Appetecchia M, Solivetti FM. The association of colour flow Doppler sonography and conventional ultrasonography improves the diagnosis of thyroid carcinoma. Horm Res. 2006;66:249–56.
Cappelli C, Castellano M, Pirola I, et al. The predictive value of ultrasound findings in the management of thyroid nodules. QJM. 2007;100:29–35.
Moon WJ, Jung SL, Lee JH, et al. Thyroid Study Group, Korean Society of Neuro- and Head and Neck Radiology. Benign and malignant thyroid nodules: US differentiation – multicenter retrospective study. Radiology. 2008;247:762–70.
Rago T, Vitti P, Chiovato L, et al. Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in ‘cold’ thyroid nodules. Eur J Endocrinol. 1998;138:41–6.
Brunese L, Romeo A, Iorio S, et al. A new marker for diagnosis of thyroid papillary cancer: B-flow twinkling sign. J Ultrasound Med. 2008;27: 1187–94.
Cerbone G, Spiezia S, Colao A, et al. Power Doppler improves the diagnostic accuracy of color Doppler ultrasonography in cold thyroid nodules: follow-up results. Horm Res. 1999;52:19–24.
Chan BK, Desser TS, McDougall IR, Weigel RJ, Jeffrey Jr RB. Common and uncommon sonographic features of papillary thyroid carcinoma. J Ultrasound Med. 2003;22:1083–90.
Solbiati L, Cioffi V, Ballarati E. Ultrasonography of the neck. Radiol Clin North Am. 1992;30:941–54.
Varverakis E, Neonakis E, Tzardi M, Chrysos E. Role of color Doppler ultrasonography in the preoperative management of cold thyroid nodules. Hormones (Athens). 2007;6:44–51.
Yuan WH, Chiou HJ, Chou YH, et al. Gray-scale and color Doppler ultrasonographic manifestations of papillary thyroid carcinoma: analysis of 51 cases. Clin Imaging. 2006;30:394–401.
Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy. J Ultrasound Med. 2004;23:1455–64.
Fobbe F, Finke R, Reichenstein E, Schleusener H, Wolf KJ. Appearance of thyroid diseases using colour-coded duplex sonography. Eur J Radiol. 1989;9:29–31.
Shimamoto K, Endo T, Ishigaki T, Sakuma S, Makino N. Thyroid nodules: evaluation with color Doppler ultrasonography. J Ultrasound Med. 1993;12:673–8.
Spiezia S, Colao A, Assanti AP, et al. Usefulness of color echo Doppler with power Doppler in the diagnosis of hypoechoic thyroid nodules: work in progress. Radiol Med. 1996;91:616–21.
Stacul F, Bertolotto M, De Gobbis F, et al. US, colour-Doppler US and fine-needle aspiration biopsy in the diagnosis of thyroid nodules. Radiol Med. 2007;112:751–62.
Moon HJ, Kwak JY, Kim MJ, Son EJ, Kim EK. Can vascularity at power Doppler US help predict thyroid malignancy? Radiology. 2010;255:260–9.
Takashima S, Fukuda H, Nomura N, et al. Thyroid nodules: re-evaluation with ultrasound. J Clin Ultrasound. 1995;23:179–84.
Cappelli C, Castellano M, Pirola I, et al. Thyroid nodule shape suggests malignancy. Eur J Endocrinol. 2006;155:27–31.
Reading CC, Charboneau JW, Hay ID, Sebo TJ. Sonography of thyroid nodules: a “classic pattern” diagnostic approach. Ultrasound Q. 2005;21:157–65.
Bonavita JA, Mayo J, Babb J, et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone? AJR Am J Roentgenol. 2009;193:207–13.
Frates MC, Benson CB, Doubilet PM, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91:3411–7.
Moon WJ, Kwag HJ, Na DG. Are there any specific ultrasound findings of nodular hyperplasia (“leave me alone” lesion) to differentiate it from follicular adenoma? Acta Radiol. 2009;50:383–8.
Ahuja A, Chick W, King W, Metreweli C. Clinical significance of the comet tail artifact in thyroid ultrasound. J Clin Ultrasound. 1996;24:129–33.
Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009;94:1748–51.
Mihailescu DV, Schneider AB. Size, number, and distribution of thyroid nodules and the risk of malignancy in radiation-exposed patients who underwent surgery. J Clin Endocrinol Metab. 2008;93:2188–93.
Alexander EK, Hurwitz S, Heering JP, et al. Natural history of benign solid and cystic thyroid nodules. Ann Intern Med. 2003;138:315–8.
Asanuma K, Kobayashi S, Shingu K, et al. The rate of tumour growth does not distinguish between malignant and benign thyroid nodules. Eur J Surg. 2001;167:102–5.
Papini E, Petrucci L, Guglielmi R, et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab. 1998;83:780–3.
Ahn SS, Kim EK, Kang DR, Lim SK, Kwak JY, Kim MJ. Biopsy of thyroid nodules: comparison of three sets of guidelines. AJR Am J Roentgenol. 2010;194:31–7.
Gharib H, Papini E, Valcavi R, et al. AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2006;12:63–102.
Filetti S, Durante C, Torlontano M. Nonsurgical approaches to the management of thyroid nodules. Nat Clin Pract Endocrinol Metab. 2006;2:384–94.
Quadbeck B, Pruellage J, Roggenbuck U, Hirche H, Janssen OE, Mann K, et al. Long-term follow-up of thyroid nodule growth. Exp Clin Endocrinol Diabetes. 2002;110:348–54.
Alexander EK, Marqusee E, Orcutt J, et al. Thyroid nodule shape and prediction of malignancy. Thyroid. 2004;14:953–8.
Roti E, degli Uberti EC, Bondanelli M, Braverman LE. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol. 2008; 159: 659–73.
Sugino K, Ito Jr K, Ozaki O, Mimura T, Iwasaki H, Ito K. Papillary microcarcinoma of the thyroid. J Endocrinol Invest. 1998;21:445–8.
Mazzaferri EL, de los Santos ET, Rofagha-Keyhani S. Solitary thyroid nodule: diagnosis and management. Med Clin North Am. 1988;72:1177–211.
Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H. Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg. 1996;131:187–91.
Berker D, Aydin Y, Ustun I, et al. The value of fine-needle aspiration biopsy in subcentimeter thyroid nodules. Thyroid. 2008;18:603–8.
Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399–407.
Cappelli C, Castellano M, Braga M, et al. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol. 2007; 95:555–60.
Popowicz B, Klencki M, Lewiński A, Słowińska-Klencka D. The usefulness of sonographic features in selection of thyroid nodules for biopsy in relation to the nodule’s size. Eur J Endocrinol. 2009;161:103–11.
Lyshchik A, Drozd V, Demidchik Y, Reiners C. Diagnosis of thyroid cancer in children: value of gray-scale and power doppler US. Radiology. 2005;235:604–13.
Mazzaferri EL, Sipos J. Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and preoperative neck ultrasonography to define the extent of tumor invasion? Thyroid. 2008;18:597–602.
Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381–7.
Kwak JY, Kim EK, Youk JH, et al. Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US. Thyroid. 2008;18:609–14.
Koike E, Noguchi S, Yamashita H, et al. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg. 2001;136:334–7.
Solbiati L, Osti V, Cova L, Tonolini M. Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol. 2001;11:2411–24.
Kuma K, Matsuzuka F, Kobayashi A, et al. Outcome of long standing solitary thyroid nodules. World J Surg. 1992;16:583–7.
Komolafe F. Radiological patterns and significance of thyroid calcification. Clin Radiol. 1981;32: 571–5.
Taki S, Terahata S, Yamashita R, et al. Thyroid calcifications: sonographic patterns and incidence of cancer. Clin Imaging. 2004;28:368–71.
Yoon DY, Lee JW, Chang SK, et al. Peripheral calcification in thyroid nodules. J Ultrasound Med. 2007;26:1349–55.
Kim BM, Kim MJ, Kim EK, et al. Sonographic differentiation of thyroid nodules with eggshell calcifications. J Ultrasound Med. 2008;27:1425–30.
Watters DA, Ahuja AT, Evans RM, et al. Role of ultrasound in the management of thyroid nodules. Am J Surg. 1992;164:654–7.
Wienke JR, Chong WK, Fielding JR, Zou KH, Mittelstaedt CA. Sonographic features of benign thyroid nodules: interobserver reliability and overlap with malignancy. J Ultrasound Med. 2003;22: 1027–31.
Marqusee E, Benson CB, Frates MC, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med. 2000;133:696–700.
Hegedüs L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003;24: |102–32.
Kunreuther E, Orcutt J, Benson CB, et al. Prevalence and distribution of carcinoma in the uninodular and multinodular goiter. Presented at the 76th Annual Meeting of the American Thyroid Association, Vancouver, British Columbia, Canada, September 29 – October 3, 2004.
Propper RA, Skolnick ML, Weinstein BJ, Dekker A. The nonspecificity of the thyroid halo sign. J Clin Ultrasound. 1980;8:129–32.
Lu C, Chang TC, Hsiao YL, Kuo MS. Ultrasonographic findings of papillary thyroid carcinoma and their relation to pathologic changes. J Formos Med Assoc. 1994;93:933–8.
Hayashi N, Tamaki N, Yamamoto K, et al. Real-time ultrasonography of thyroid nodules. Acta Radiol Diagn (Stockh). 1986;27:403–8.
Hoang JK, Lee WK, Lee M, Johnson D, Farrell S. US Features of thyroid malignancy: pearls and pitfalls. Radiographics. 2007;27:847–60.
Cappelli C, Pirola I, Cumetti D, et al. Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine-needle aspiration cytology? Clin Endocrinol (Oxf). 2005;63:689–93.
Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995;196:123–34.
Yoon SJ, Yoon DY, Chang SK, et al. “Taller-than-wide sign” of thyroid malignancy: comparison between ultrasound and CT. AJR Am J Roentgenol. 2010;194:W420–4.
Brkljacić B, Cuk V, Tomić-Brzac H, Bence-Zigman Z, Delić-Brkljacić D, Drinković I. Ultrasonic evaluation of benign and malignant nodules in echographically multinodular thyroids. J Clin Ultrasound. 1994;22: 71–6.
Lagalla R, Cariso G, Midiri M, Cardinale AE. Echo-Doppler couleru et pathologie thyroidienne. J Echograph Med Ultrasons. 1992;13:44–7.
Berni A, Tromba L, Falvo L, Marchesi M, Grilli P, Peparini N. Malignant thyroid nodules: comparison between color Doppler diagnosis and histological examination of surgical samples. Chir Ital. 2002;54: 643–7.
Tamsel S, Demirpolat G, Erdogan M, et al. Power Doppler US patterns of vascularity and spectral Doppler US parameters in predicting malignancy in thyroid nodules. Clin Radiol. 2007;62:245–51.
Bakhshaee M, Davoudi Y, Mehrabi M, et al. Vascular pattern and spectral parameters of power Doppler ultrasound as predictors of malignancy risk in thyroid nodules. Laryngoscope. 2008;118: 2182–6.
De Nicola H, Szejnfeld J, Logullo AF, Wolosker AM, Souza LR, Chiferi Jr V. Flow pattern and vascular resistive index as predictors of malignancy risk in thyroid follicular neoplasms. J Ultrasound Med. 2005;24:897–904.
Levine RA. Doppler ultrasound. In: Baskin HJ, Duick DS, Levine RA, editors. Thyroid ultrasound and ultrasound-guided FNA. 2nd ed. New York: Springer Science; 2008. p. 30–5.
Levine RA. Value of Doppler ultrasonography in management of patients with follicular thyroid biopsy specimens. Endocr Pract. 2006;12:270–4.
Ahuja AT, Ying M, Ho SY, Antonio G, Lee YP, King AD, et al. Ultrasound of malignant cervical lymph nodes. Cancer Imaging. 2008;8:48–56.
Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab. 2007;92:3590–4.
Kuna SK, Bracic I, Tesic V, et al. Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med. 2006;25:1531–7.
Kessler A, Rappaport Y, Blank A, Marmor S, Weiss J, Graif M. Cystic appearance of cervical lymph nodes is characteristic of metastatic papillary thyroid carcinoma. J Clin Ultrasound. 2003;31:21–5.
McGregor GI, Luomo A, Jackson SM. Lymph node metastases from well-differentiated thyroid cancer: a clinical review. Am J Surg. 1985;149:610.
Hamberger B, Gharib H, Melton 3rd LJ, Goellner JR, Zinsmeister AR. Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med. 1982;73:381–4.
Mittendorf EA, Tamarkin SW, McHenry CR. The results of ultrasound-guided fine-needle aspiration biopsy for evaluation of nodular thyroid disease. Surgery. 2002;132:648–53.
Jemal A, Murray T, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.
Bruneton JN, Normand F. Thyroid gland. In: Bruneton JN, editor. Ultrasonography of the neck. Berlin: Springer; 1987. p. 22–50.
Rustgi AK. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med. 1994;331:1694–702.
LiVolsi VA. Pathology of thyroid disease. In: Flak SA, editor. Thyroid disease: endocrinology, surgery, nuclear medicine and radiotherapy. Philadelphia: Lippincott-Raven; 1997. p. 70–5.
Chow SM, Chan JK, Law SC, et al. Diffuse sclerosing variant of papillary thyroid carcinoma – clinical features and outcome. Eur J Surg Oncol. 2003;29: 446–9.
Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol. 1989;13:1041–9.
Fujimoto Y, Obara T, Ito Y, Kodama T, Aiba M, Yamaguchi K. Diffuse sclerosing variant of papillary carcinoma of the thyroid. Clinical importance, surgical treatment, and follow-up study. Cancer. 1990;66:2306–12.
Lam AK, Lo CY. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol. 2006;13:176–81.
Vickery Jr AL, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M. Papillary carcinoma. Semin Diagn Pathol. 1985;2:90–100.
Lee JY, Shin JH, Han BK, et al. Diffuse sclerosing variant of papillary carcinoma of the thyroid: imaging and cytologic findings. Thyroid. 2007;17:567–73.
Filie AC, Chiesa A, Bryant BR, Merino MJ, Sobel ME, Abati A. The Tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms. Cancer. 1999;87:238–42.
Prendiville S, Burman KD, Ringel MD, et al. Tall cell variant: an aggressive form of papillary thyroid carcinoma. Otolaryngol Head Neck Surg. 2000;122:352–7.
Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol. 1996;20:964–74.
Putti TC, Bhuiya TA. Mixed columnar cell and tall cell variant of papillary carcinoma of thyroid: a case report and review of the literature. Pathology. 2000;32:286–9.
Jayaram G. Cytology of columnar-cell variant of papillary thyroid carcinoma. Diagn Cytopathol. 2000;22:227–9.
Sobrinho-Simões M, Nesland JM, Johannessen JV. Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol. 1988;89:264–7.
Ahuja AT. The thyroid and parathyroids. In: Ahuja AT, Evans RM, editors. Practical head and neck ultrasound. London: Greenwich Medical Media Limited; 2000. p. 35–64.
Solbiati L, Livraghi T, Ballarati E, Ierace T, Crespi L. Thyroid gland. In: Solbiati L, Rizzatto G, editors. Ultrasound of superficial structures. London: Churchill Livingstone; 1995. p. 49–85.
Simeone JF, Daniels GH, Mueller PR, et al. High resolution real time sonography of the thyroid. Radiology. 1982;145:431–5.
Solbiati L, Volterrani L, Rizzatto G, et al. The thyroid gland with low uptake lesions: evaluation with ultrasound. Radiology. 1985;155:187–91.
Noyek AM, Finkelstein DM, Witterick IJ, Kirsch JC. Diagnostic imaging of the thyroid gland. In: Falk SA, editor. Thyroid disease: endocrinology, surgery, nuclear medicine, and radiotherapy. New York: Raven Press; 1997. p. 137–9.
McIvor NP, Freeman JL, Salem S. Ultrasonography of the thyroid and parathyroid glands. ORL J Otorhinolaryngol Relat Spec. 1993;55:303–8.
Kim HS, Han BK, Shin JH, et al. Papillary thyroid carcinoma of a diffuse sclerosing variant: ultrasonographic monitoring from a normal thyroid gland to mass formation. Korean J Radiol. 2010;11:579–82.
Ahuja AT, Chow L, Chick W, et al. Metastatic cervical nodes in papillary carcinoma of the thyroid: ultrasound and histological correlation. Clin Radiol. 1995;50:229–31.
DeMay RM. Follicular lesions of the thyroid. W(h)ither follicular carcinoma? Am J Clin Pathol. 2000;114:681–3.
Baloch ZW, LiVolsi VA. Our approach to follicular-patterned lesions of the thyroid. J Clin Pathol. 2007;60:244–50.
Greaves TS, Olvera M, Florentine BD, et al. Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer. 2000;90:335–41.
Saggiorato E, De Pompa R, Volante M, et al. Characterization of thyroid ‘follicular neoplasms’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer. 2005;12:305–17.
Tombouret R, Szefelbein WM, Pitman MB. Ultrasound-guided fine-needle aspiration biopsy of the thyroid. Cancer. 1999;87:299–305.
Williams ED, Doinach I, Bjanarson O, Michie W. Thyroid cancer in an iodide rich area. Cancer. 1977;39:215–22.
Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol. 1986;10:246–55.
Lin JD, Hsueh C, Chao TC, Weng JF, Huang BY. Thyroid follicular neoplasms diagnosed by high-resolution ultrasonography with fine needle aspiration cytology. Acta Cytol. 1997;41:687–91.
Iared W, Shigueoka DC, Cristófoli JC, et al. Use of color Doppler ultrasonography for the prediction of malignancy in follicular thyroid neoplasms: systematic review and meta-analysis. J Ultrasound Med. 2010;29:419–25.
Bondeson L, Bondeson AG, Ljungberg O, Tibblin S. Oxyphil tumors of the thyroid: follow-up of 42 surgical cases. Ann Surg. 1981;194:677–80.
Caplan RH, Abellera RM, Kisken WA. Hürthle cell tumors of the thyroid gland. A clinicopathologic review and long-term follow-up. JAMA. 1984;251:3114–7.
Chesky VE, Dreese WC, Hellwig CA. Hürthle cell tumors of the thyroid gland: a report on 25 cases. J Clin Endocrinol Metab. 1951;11:1535–48.
Frazell EL, Duffy Jr BJ. Hürthle-cell cancer of the thyroid; a review of forty cases. Cancer. 1951;4:952–6.
Gosain AK, Clark OH. Hürthle cell neoplasms. Malignant potential. Arch Surg. 1984;119:515–9.
Horn Jr RC. Hürthle-cell tumors of the thyroid. Cancer. 1954;7:234–44.
Saull SC, Kimmelman CP. Hürthle cell tumors of the thyroid gland. Otolaryngol Head Neck Surg. 1985;93:58–62.
Phitayakorn R, McHenry CR. Follicular and Hürthle cell carcinoma of the thyroid gland. Surg Oncol Clin N Am. 2006;15:603–23.
Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH. Hürthle cell lesions of the thyroid gland. Surg Gynecol Obstet. 1974;139:555–60.
Gundry SR, Burney RE, Thompson NW, Lloyd R. Total thyroidectomy for Hürthle cell neoplasm of the thyroid. Arch Surg. 1983;118:529–32.
Yutan E, Clark OH. Hürthle cell carcinoma. Curr Treat Options Oncol. 2001;2:331–5.
Tollefsen HR, Shah JP, Huvos AG. Hürthle cell carcinoma of the thyroid. Am J Surg. 1975;130:390–4.
Chiacchio S, Lorenzoni A, Boni G, Rubello D, Elisei R, Mariani G. Anaplastic thyroid cancer: prevalence, diagnosis and treatment. Minerva Endocrinol. 2008;33:341–57.
Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol. 2006;13:453–64.
Takashima S, Morimoto S, Ikezoe J, et al. CT evaluation of anaplastic thyroid carcinoma. Am J Roentgenol. 1990;154:61–3.
Compagno J. Diseases of the thyroid. In: Barnes L, editor. Surgical pathology of the head and neck. New York: Marcel Dekker; 1985. p. 1435–86.
LiVolsi VA. Calcitonin: the hormone and its significance. Prog Surg Pathol. 1980;1:71–103.
Steiner AL, Goodman AD, Powers SR. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing’s disease: multiple endocrine neoplasia, type 2. Medicine (Baltimore). 1968;47:371–409.
LiVolsi VA. Medullary carcinoma. In: LiVolsi VA, editor. Surgical pathology of the thyroid. Philadelphia: WB Saunders Co.; 1990. p. 217–20.
Hazard JB, The C. Cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review. Am J Pathol. 1977;88:213–50.
Mendelsohn G, Eggleston JC, Weisburger WR, Gann DS, Baylin SB. Calcitonin and histaminase in C-cell hyperplasia and medullary thyroid carcinoma. A light microscopic and immunohistochemical study. Am J Pathol. 1978;92:35–52.
Wolfe HJ, Melvin KE, Cervi-Skinner SJ, et al. C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med. 1973;289:437–41.
Aliapoulios MA, Kacoyanis GP. Primary and metastatic medullary thyroid carcinoma. Determination of thyrocalcitonin content by bioassay. Arch Surg. 1973;106:105–8.
Deftos LJ. Radioimmunoassay for calcitonin in medullary thyroid carcinoma. JAMA. 1974;227:403–6.
Dubé WJ, Bell GO, Aliapoulios MA. Thyrocalcitonin activity in metastatic medullary thyroid carcinoma. Further evidence for its parafollicular cell origin. Arch Intern Med. 1969;123:423–7.
Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology; 1992. p. 207–9.
Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer. 2000;88:1139–48.
Pelizzo MR, Boschin IM, Bernante P, et al. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients. Eur J Surg Oncol. 2007;33:493–7.
Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107:2134–42.
Lee S, Shin JH, Han BK, Ko EY. Medullary thyroid carcinoma: comparison with papillary thyroid carcinoma and application of current sonographic criteria. AJR Am J Roentgenol. 2010;194:1090–4.
Anscombe AM, Wright DH. Primary malignant lymphoma of the thyroid – a tumour of mucosa associated lymphoid tissue: review of seventy-six cases. Histopathology. 1985;9:81–7.
Burke JS, Butler JJ, Fuller LM. Malignant lymphomas of the thyroid. Cancer. 1977;39:1587–602.
Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer. 1983;52:1849–55.
Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am J Surg Pathol. 1984;8:655–68.
Papotti M, Botto Micca F, Favero A, Palestini N, Bussolati G. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol. 1993;17: 291–301.
Burman KD, Ringel MD, Wartofsky L. Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am. 1996;25:49–68.
Johnson NA, Tublin ME. Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies. Radiology. 2008;249:429–44.
Schlumberger M, Berg G, Cohen O, et al. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol. 2004;150:105–12.
Toubeau M, Touzery C, Arveux P, et al. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med. 2004;45:988–94.
Rouxel A, Hejblum G, Bernier MO, et al. Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2004;89:5362–8.
Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases. Cancer. 1998;82:740–53.
Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer. 2000;88:1902–8.
Kim TY, Kim WB, Kim ES, et al. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2005;90:1440–5.
Aygun N. Imaging of recurrent thyroid cancer. Otolaryngol Clin North Am. 2008;41:1095–106.
Lind P, Kohlfürst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med. 2006;36:194–205.
Sheth S, Hamper UM. Role of sonography after total thyroidectomy for thyroid cancer. Ultrasound Q. 2008;24:147–54.
Shin JH, Han BK, Ko EY, Kang SS. Sonographic findings in the surgical bed after thyroidectomy: comparison of recurrent tumors and nonrecurrent lesions. J Ultrasound Med. 2007;26:1359–66.
Wong KT, Choi FP, Lee YY, Ahuja AT. Current role of radionuclide imaging in differentiated thyroid cancer. Cancer Imaging. 2008;8:159–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary material
24-Malignant nodule in diffuse multinodular goiter (6,757 KB)
25-Classic papillary carcinoma, transverse view(6,120 KB)
26-Classic papillary carcinoma, sagittal view (6,129 KB)
27-Large complex papillary carcinoma, transverse view (72,653 KB)
28-Large complex papillary carcinoma, sagittal view (70,874 KB)
29-Large papillary carcinoma with adjacent lymph node metast (6,329 KB)
30-Malignant intranodal vascularity (4,664 KB)
31-Microcalcifications in papillary carcinoma transverse vie (1,115 KB)
32-Microcalcifications in papillary carcinoma, sagittal view (1,115 KB)
33-Nodule with punctate hyperlucencies representing microcal (6,120 KB)
34-Papillary carcinoma demonstrating extracapsular extension (6,123 KB)
35-Papillary carcinoma, extracapsular extension, Power Doppl (6,723 KB)
36-Small nodule, 'taller than wide' representing papillary c (6,139 KB)
37-Small papillary carcinoma with adjacent lymph node metast (5,929 KB)
38-Prior left thyroid lobectomy for a benign lesion. Incide (80,510 KB)
39-Medullary carcinoma of thyroid gland with ipsilateral ce (61,445 KB)
40-Medullary carcinoma of thyroid gland. Note focal hyperlu (75,718 KB)
41-Metastatic medullary carcinoma to zone IV lymph nodes, tr (56,974 KB)
42-Metastatic medullary carcinoma to zone IV lymph nodes, sa (57,443 KB)
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Wong, K.T., Lee, Y.Y.P., Ahuja, A.T. (2012). Malignant Thyroid Conditions. In: Sofferman, R., Ahuja, A. (eds) Ultrasound of the Thyroid and Parathyroid Glands. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0974-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0974-8_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0973-1
Online ISBN: 978-1-4614-0974-8
eBook Packages: MedicineMedicine (R0)